EVENT | ADVANCED THERAPIES

The Advanced Therapies Congress is Europe´s largest cell and gene therapy conference and exhibition. The event is for the leaders of the world´s ATMPs developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.

The Advanced Therapies Congress is Europe´s largest cell and gene therapy conference and exhibition. The event is for the leaders of the world´s ATMPs developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.
February 20, 2023

March 14-15 | ExCel, London

Join Asphalion at the Advanced Therapies Congress!! The event will be held in London and our experts Chris Mann and Oriol Penon will be available at BOOTH #74 to present you Asphalion and all the solutions we can provide you with, as well as to discuss all your regulatory needs.

ATMPs complexity requires specific development approaches and regulatory adaptations to overcome the challenging environment involving ATMPs. Asphalion’s team has specific expertise and broad scientific background in regulatory strategy, CMC and clinical development in ATMPs.

Asphalion can elaborate all regulatory, non-clinical, clinical and CMC documentation required during development, registration and lifecycle of ATMPs. In addition, strategic inputs can be given from the very beginning for segmentation/niche indication, conditional approval/fast track, orphan drug designations, preclinical and clinical development plans with minimum time-to-market.

If you want to schedule a meeting, you can send an email at: info@asphalion.com

Looking forward to meet you in London!

Event Info

a

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | 20th Biosimilar Medicines Conference by MFE

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

BUSINESS CASE | Transparency policy 0070

Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full regulatory support for the management of Policy 0070

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting